Treatment of type 1 diabetes in children and adolescents using modern insulin pumps

Diabetes Research and Clinical Practice - Tập 93 - Trang S118-S124 - 2011
Olga Kordonouri1, Reinhard Hartmann1, Thomas Danne1
1Bult Diabetes Centre for Children and Adolescents, Kinderkrankenhaus auf der Bult, Hannover, Germany

Tài liệu tham khảo

DCCT Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 DCCT Group, 1994, Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, J Pediatr, 125, 177, 10.1016/S0022-3476(94)70190-3 Prince, 2007, Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC), Diabetologia, 50, 2280, 10.1007/s00125-007-0797-7 Mortensen, 1998, Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes, Diabetic Med, 15, 752, 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W Holder, 2007, Trends in der Insulinpumpentherapie bei Kindern, Jugendlichen und jungen Erwachsenen mit Typ-1-Diabetes von 1995-2006: Daten der DPV-Initiative, Diabetologie, 2, 169, 10.1055/s-2007-960666 Boland, 1999, Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes, Diabetes Care, 22, 1779, 10.2337/diacare.22.11.1779 Danne, 2008, Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries, Diabetologia, 51, 1594, 10.1007/s00125-008-1072-2 Phillip, 2007, Diabetes Care, 30, 1653, 10.2337/dc07-9922 Berghaeuser, 2008, German working group for insulin pump treatment in paediatric patients. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria, Pediatr Diabetes, 9, 590, 10.1111/j.1399-5448.2008.00416.x Danne, 2006, Current practice of insulin pump therapy in children and adolescents - the Hannover recipe, Pediatr Diabetes, 7, 25, 10.1111/j.1399-543X.2006.00166.x Ahern, 2002, Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbAlc levels across all age groups, Pediatr Diabetes, 3, 10, 10.1034/j.1399-5448.2002.30103.x Hanas, 2002, Selection for and initiation of continuous subcutaneous insulin infusion, Horm Res, 57, 101 Holterhus, 2007, Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy, Diabetes Care, 30, 568, 10.2337/dc06-2105 Danne, 2005, A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries, Pediatr Diabetes, 6, 193, 10.1111/j.1399-543X.2005.00131.x Klinkert, 2008, Age-specific characteristics of the basal insulin-rate for pediatrie patients on CSII, Exp Clin Endocrinol Diabetes, 116, 118, 10.1055/s-2007-990296 O'Connell, 2008, Optimizing postprandial glycemia in pediatrie patients with typel diabetes using insulin pump therapy, Diabetes Care, 31, 1491, 10.2337/dc08-0306 Chase, 2002, Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes, Diabet Med, 19, 317, 10.1046/j.1464-5491.2002.00685.x Pankowska, 2009, Application of novel dual wave meal bolus and its impact on glycated hemoglobin Ale level in children with type 1 diabetes, Pediatr Diabetes, 10, 298, 10.1111/j.1399-5448.2008.00471.x Tubiana-Rufi, 2004, Special management of insulin lispro in continuous subcutaneous insulin infusion in young diabetic children: a randomized cross-over study, Horm Res, 62, 265 Jorgensen, 2005, Dilution of Novolog (insulin aspart 100 U/ml) with NPH medium for small dose use in continuous subcutaneous insulin infusion does not affect in-vitro stability, Diabetes, 54, A102 Bharucha, 2005, Neonatal diabetes mellitus: insulin pump as an alternative management strategy, J Paediatr Child Health, 41, 522, 10.1111/j.1440-1754.2005.00696.x Danne, 2001, Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group, Diabetes Care, 24, 1342, 10.2337/diacare.24.8.1342 Jakisch, 2008, Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years, Diabet Med, 25, 80, 10.1111/j.1464-5491.2007.02311.x Kordonouri, 2006, Age-specific advantages of continuous subcutaneous insulin infusion (CSII) as compared with multiple daily injections (MDI) in pediatrie patients: one year follow-up comparison by matched-pair analysis, Diabetes Care, 29, 133, 10.2337/diacare.29.01.06.dc05-1740 Nimri, 2006, Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study, Pediatrics, 117, 2126, 10.1542/peds.2005-2621 Pickup, 2008, Severe hypoglycaemia and glycaemic control in Typel diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Medicine, 25, 765, 10.1111/j.1464-5491.2008.02486.x Jeitler, 2008, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis, Diabetologia, 51, 941, 10.1007/s00125-008-0974-3 Pankowska, 2009, Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials, Pediatr Diabetes, 10, 52, 10.1111/j.1399-5448.2008.00440.x Misso, 2010, Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus, Cochrane Database Syst Rev, 1 Weissberg-Benchell, 2003, Insulin pump therapy: a meta-analysis, Diabetes Care, 26, 1079, 10.2337/diacare.26.4.1079 Pickup, 2002, Continuous subcutaneous insulin infusion at 25years: Evidence base for the expanding use of insulin pump therapy in typel diabetes, Diabetes Care, 25, 593, 10.2337/diacare.25.3.593 Linkeschova, 2002, Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years, Diabet Med, 19, 746, 10.1046/j.1464-5491.2002.00713.x Knight, 2009, Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with typel diabetes mellitus: a pilot study, Diabetologia, 52, 193, 10.1007/s00125-008-1197-3 Halvorson, 2007, A Pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump, J Pediatr, 150, 103, 10.1016/j.jpeds.2006.08.069 Hirsch, 2008, Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study, Diabetes Technol Ther, 10, 377, 10.1089/dia.2008.0068 The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2008, Continuous glucose monitoring and intensive treatment of type 1 diabetes, N Engl J Med, 359, 1464, 10.1056/NEJMoa0805017 The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2009, Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes, Diabetes Care, 32, 1947, 10.2337/dc09-0889 Kordonouri, 2010, Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes - results of the pediatrie ONSET study after 12 months of treatment, Diabetologia, 53, 2487, 10.1007/s00125-010-1878-6